Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead compound voclosporin, a therapeutic immunomodulating drug candidate, which is a second-generation calcineurin inhibitors (CNI) to treat patients afflicted with LN. Voclosporin is an oral drug, administered twice daily. It is structurally similar to cyclosporine A (CsA), but is chemically modified on the amino acid-1 residue. It has completed two Phase III clinical studies in patients with moderate to severe psoriasis. It has completed Phase IIb clinical trial, which is a randomized, controlled, double-blind study comparing the efficacy of voclosporin as a component of multi-targeted therapy against placebo in achieving remission in patients with active LN.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: TSE:ISA
- CUSIP: N/A
- Web: N/A
- Trailing P/E Ratio:
- P/E Growth:
Frequently Asked Questions for Aurinia Pharmaceuticals (TSE:ISA)
What is Aurinia Pharmaceuticals' stock symbol?
Aurinia Pharmaceuticals trades on the Tornton Stock Exchange (TSX) under the ticker symbol "ISA."
Who are some of Aurinia Pharmaceuticals' key competitors?
Some companies that are related to Aurinia Pharmaceuticals include Colliers International Group (CIG), Kirkland Lake Gold Ltd (NMI), Osisko Mining Corp (OBM), Royal Bank of Canada (RY), Toronto-Dominion Bank (TD), Bank of Nova Scotia (BNS), Enbridge (ENB), Canadian National Railway Company (CNR), Suncor Energy (SU), Bank of Montreal (BMO), TransCanada (TRP), BCE (BCE), Manulife Financial Corp. (MFC), Canadian Natural Resources Limited (CNQ), Thomson Reuters Corp (TRI), Canadian Imperial Bank of Commerce (CM), Great-West Lifeco (GWO) and Imperial Oil Ltd (IMO).
How do I buy Aurinia Pharmaceuticals stock?
Shares of Aurinia Pharmaceuticals and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
Consensus Ratings for Aurinia Pharmaceuticals (TSE:ISA) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Aurinia Pharmaceuticals (TSE:ISA)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Aurinia Pharmaceuticals (TSE:ISA)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Aurinia Pharmaceuticals (TSE:ISA)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Aurinia Pharmaceuticals (TSE:ISA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Aurinia Pharmaceuticals (TSE:ISA)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Aurinia Pharmaceuticals (TSE:ISA)
Latest Headlines for Aurinia Pharmaceuticals (TSE:ISA)
Aurinia Pharmaceuticals (ISA) Chart for Saturday, May, 27, 2017